Advertisement
Advertisement

TECX

TECX logo

Tectonic Therapeutic, Inc. Common Stock

30.98
USD
Sponsored
+0.76
+2.51%
Aug 07, 15:58 UTC -4
Closed
exchange

After-Market

30.95

-0.03
-0.08%

Tectonic Therapeutic, Inc. Common Stock Profile

About

Tectonic Therapeutic Inc. is a biotechnology company developing GPCR -targeted therapeutic proteins. Tectonic Therapeutic Inc., formerly known as AVROBIO Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Alise Reicin

Headquarters

490 ARSENAL WAY, SUITE 200
WATERTOWN, MA 02472, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.tectonictx.com

Auditor

Deloitte & Touche LLP

Share holders

30

Employees

60

Tectonic Therapeutic, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

584.10M

Enterprise Value

357.21M

Enterprise Value/EBITDA(ttm)

-3.81

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.53

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-34.35%

Return on Invested Capital(ttm)

-32.75%

Return on Assets(ttm)

-32.80%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-93.66M

Net Income Available to Common(ttm)

-85.79M

Diluted EPS(ttm)

-4.57

Share Statistics

Beta (5Y Monthly)

3.28

52-Week Change

41.33%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

19.55M

Dividend Yield

0.00%

Float4

11.36M

% Held by Insiders

39.80%

% Held by Institutions

62.63%

Balance Sheet

Total Cash(mrq)

227.07M

Total Cash Per Share(mrq)

11.62

Total Debt(mrq)

186.00K

Total Debt/Equity(mrq)

0.12%

Current Ratio(mrq)

18.51%

Quick Ratio(mrq)

18.51%

Book Value Per Share(mrq)

12.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.98

Free Cash Flow(ytd)

-18.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement